Background: The potential role of bevacizumab in the treatment of ovarian granulosa-cell tumors has not been evaluated. Case: An 82 year old woman with refractory ovarian granulosa-cell carcinoma was treated with bevacizumab with symptomatic relief of ascites. Conclusion: Bevacizumab may have a role in the management of malignant ascites in the patient with refractory granulosa-cell carcinoma of the ovary which should be confirmed in a larger series of well selected patients.
All Science Journal Classification (ASJC) codes
- Obstetrics and Gynecology